Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Similares em SciELO
Compartilhar
Cirujano general
versão impressa ISSN 1405-0099
Resumo
ORTIZ-RUVALCABA, Óscar I et al. Preliminary report on effectiveness of the Spatz-3® balloon in a sample of female patients in Juarez, Mexico. Cir. gen [online]. 2022, vol.44, n.3, pp.109-115. Epub 20-Out-2023. ISSN 1405-0099. https://doi.org/10.35366/109769.
Introduction:
obesity is a high-mortality pandemic. Its treatment is multidisciplinary and is based on lifestyle changes with limited benefit. The use of intragastric devices is a treatment for weight loss, especially when the patient is unfit or denies surgery.
Objective:
to evaluate the results of treatment with the intragastric device Spatz-3® in a period of 12 months.
Material and methods:
a longitudinal study is carried out to evaluate the efficacy of the intragastric device Spatz-3® in a private endoscopic center in northern Mexico; and 27 female patients were analyzed between January 2019 and December 2021.
Results:
an average decrease in total weight of 14.2 kg (14.6% of total body weight and 37.6% of excess weight lost) was observed at 12 months. Despite a lower effectiveness than that reported in surgical treatment, DIG has a higher effectiveness compared to conservative interventions based on changing the patient’s lifestyle.
Conclusion:
the intragastric device Spatz-3® showed a considerable reduction in total weight, being also a method with a lower rate of complications and completely reversible.
Palavras-chave : gastric balloon; stomach; obesity; obesity management; women.